Evidence map›Paper›PMID 31261630›Full record

ArticleInternational journal of environmental research and public health2019

The Korea Cancer Big Data Platform (K-CBP) for Cancer Research.

Hyo Soung Cha, Jip Min Jung, Seob Yoon Shin, Young Mi Jang, Phillip Park, Jae Wook Lee, Seung Hyun Chung, Kui Son Choi

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hyo Soung ChaCancer Big Data Center, National Cancer Control Institute, National Cancer Center, Goyang 10408, Korea.ORCID 0000-0003-0537-8355
Jip Min JungCancer Big Data Center, National Cancer Control Institute, National Cancer Center, Goyang 10408, Korea.
Seob Yoon ShinCancer Big Data Center, National Cancer Control Institute, National Cancer Center, Goyang 10408, Korea.ORCID 0000-0003-0104-0947
Young Mi JangCancer Big Data Center, National Cancer Control Institute, National Cancer Center, Goyang 10408, Korea.
Phillip ParkCancer Big Data Center, National Cancer Control Institute, National Cancer Center, Goyang 10408, Korea.
Jae Wook LeeCancer Big Data Center, National Cancer Control Institute, National Cancer Center, Goyang 10408, Korea.
Seung Hyun ChungCancer Big Data Center, National Cancer Control Institute, National Cancer Center, Goyang 10408, Korea.
Kui Son ChoiDepartment of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang 10408, Korea. kschoi@ncc.re.kr.ORCID 0000-0001-5336-3874

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Data warehousing is the most important technology to address recent advances in precision medicine. However, a generic clinical data warehouse does not address unstructured and insufficient data. In precision medicine, it is essential to develop a platform that can collect and utilize data. Data were collected from electronic medical records, genomic sequences, tumor biopsy specimens, and national cancer control initiative databases in the National Cancer Center (NCC), Korea. Data were de-identified and stored in a safe and independent space. Unstructured clinical data were standardized and incorporated into cancer registries and linked to cancer genome sequences and tumor biopsy specimens. Finally, national cancer control initiative data from the public domain were independently organized and linked to cancer registries. We constructed a system for integrating and providing various cancer data called the Korea Cancer Big Data Platform (K-CBP). Although the K-CBP could be used for cancer research, the legal and regulatory aspects of data distribution and usage need to be addressed first. Nonetheless, the system will continue collecting data from cancer-related resources that will hopefully facilitate precision-based research.

Indexed as

Big DataDatabases, FactualElectronic Health RecordsHumansNeoplasmsPrecision MedicineRegistriesRepublic of Koreabig data platformcancer dataclinical cancer registryde-identification

Identifiers

PMID31261630
PMCPMC6651426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.